- Patent Title: Benzenesulfonamide compounds and their use as therapeutic agents
-
Application No.: US16440459Application Date: 2019-06-13
-
Publication No.: US10745392B2Publication Date: 2020-08-18
- Inventor: Kristen Nicole Burford , Thilo Focken , Verner Alexander Lofstrand , Michael Scott Wilson , Alla Yurevna Zenova
- Applicant: Xenon Pharmaceuticals Inc.
- Applicant Address: CA Burnaby
- Assignee: Xenon Pharmaceuticals Inc.
- Current Assignee: Xenon Pharmaceuticals Inc.
- Current Assignee Address: CA Burnaby
- Agency: Fish & Richardson P.C.
- Main IPC: C07D417/12
- IPC: C07D417/12 ; A61P25/08 ; C07D277/52 ; C07D413/12
Abstract:
This invention is directed to benzenesulfonamide compounds, as stereoisomers, enantiomers, tautomers thereof or mixtures thereof; or pharmaceutically acceptable salts, solvates or prodrugs thereof, for the treatment of diseases or conditions associated with voltage-gated sodium channels, such as epilepsy and/or epileptic seizure disorders.
Public/Granted literature
- US20190382398A1 BENZENESULFONAMIDE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS Public/Granted day:2019-12-19
Information query
